OPKO Health, Inc.
Tel Aviv Stock ExchangeTotal Valuation
OPKO Health, Inc. carries a market capitalization of 3.53B, placing it among publicly traded companies globally. Its enterprise value stands at 87.87B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 3.53B |
| Enterprise Value | 87.87B |
Share Statistics
OPKO Health, Inc. currently has 755.09M shares outstanding.
| Shares Outstanding | 755.09M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 151.11, and the price-to-book ratio stands at -37.56.
| PE Ratio | N/A |
| PS Ratio | 151.11 |
| PB Ratio | -37.56 |
| P/TBV Ratio | 2,833.49 |
| P/FCF Ratio | -537.75 |
| P/OCF Ratio | -537.75 |
Enterprise Valuation
| EV / Sales | 151.20 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | N/A |
Financial Position
OPKO Health, Inc. maintains a current ratio of 3.61, meaning it holds 3.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 32.95, indicating elevated leverage, while an interest coverage ratio of -1.08 demonstrates limited ability to service its debt obligations.
| Current Ratio | 3.61 |
| Quick Ratio | 3.03 |
| Debt / Equity | 32.95 |
| Debt / EBITDA | -3.53 |
| Interest Coverage | -1.08 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -10.69 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | -3.09 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 5.80 |
Taxes
Over the trailing twelve months, OPKO Health, Inc. has paid -16.05M in income taxes, reflecting an effective tax rate of 47.78.
| Income Tax | -16.05M |
| Effective Tax Rate | 47.78 |
Stock Price Statistics
OPKO Health, Inc.'s stock has gained approximately 2.14021% over the past 52 weeks. The 50-day moving average sits at 383.53, while the 200-day moving average is 405.18.
| Beta (5Y) | N/A |
| 52-Week Price Change | 2.14021% |
| 50-Day Moving Average | 383.53 |
| 200-Day Moving Average | 405.18 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, OPKO Health, Inc. generated 581.12M in revenue and converted that into -212.91M in net income, yielding earnings per share of -0.28. EBITDA reached -112.49M, while operating income came in at -202.83M.
| Revenue | 581.12M |
| Gross Profit | 209.08M |
| Operating Income | -202.83M |
| Pretax Income | -228.95M |
| Net Income | -212.91M |
| EBITDA | -112.49M |
| EBIT | -202.83M |
| Earnings Per Share (EPS) | -0.28 |
Balance Sheet
OPKO Health, Inc. holds 341.88M in cash and equivalents against 396.93M in total debt, resulting in a net debt position of 3.79M. Total book value stands at -2.34B, with working capital of 386.98M providing operational flexibility.
| Cash & Cash Equivalents | 341.88M |
| Total Debt | 396.93M |
| Net Debt | 3.79M |
| Equity (Book Value) | -2.34B |
| Book Value Per Share | -3.03 |
| Working Capital | 386.98M |
Cash Flow
OPKO Health, Inc. produced -163.30M in operating cash flow over the past twelve months.
| Operating Cash Flow | -163.30M |
| Capital Expenditures | N/A |
| Free Cash Flow | -163.30M |
| FCF Per Share | -0.21 |
Margins
OPKO Health, Inc. operates with a gross margin of 35.98, reflecting its pricing power and cost economics. The operating margin of -34.90 and net profit margin of -36.64 provide insight into operational efficiency.
| Gross Margin | 35.98 |
| Operating Margin | -34.90 |
| Pretax Margin | -39.40 |
| Profit Margin | -36.64 |
| EBITDA Margin | -19.36 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 0.14 |
| FCF Yield | -0.19 |
Scores
OPKO Health, Inc. posts an Altman Z-Score of 76.53, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 76.53 |